![Emmanuel Lacroix](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emmanuel Lacroix
Director/Miembro de la Junta en Lumos Pharma Sub, Inc. .
Cargos activos de Emmanuel Lacroix
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Director/Miembro de la Junta | - | - |
UCB Ventures (Private Equity)
![]() UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures is the venture capital arm of UCB SA and was founded in 2016. UCB Ventures is headquartered in Brussels, Belgium with additional offices in Boston, Massachusetts and London, United Kingdom. | Inversor de Capital Privado | 01/04/2017 | - |
Walden Biosciences, Inc.
![]() Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Director/Miembro de la Junta | - | - |
Syndesi Therapeutics SA
![]() Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Director/Miembro de la Junta | - | - |
EsoBiotec SA
![]() EsoBiotec SA Miscellaneous Commercial ServicesCommercial Services EsoBiotec SA is a Belgian company that provides research and development on natural sciences and engineering. The company is based in Charleroi, Belgium. The company was founded in 2020 by Jean-Pierre Latere. Jean-Pierre Latere has been the CEO since 2020. | Director/Miembro de la Junta | 31/08/2021 | - |
Arix Bioscience /Venture Capital/
![]() Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Inversor de Capital Privado | 01/08/2022 | - |
Historial de carrera de Emmanuel Lacroix
Antiguos cargos conocidos de Emmanuel Lacroix.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
UCB | Corporate Officer/Principal | 12/03/2013 | - |
Formación de Emmanuel Lacroix.
Université Libre de Bruxelles | Graduate Degree |
University of Liege | Undergraduate Degree |
IMD College | Masters Business Admin |
Estadísticas
Internacional
Bélgica | 7 |
Estados Unidos | 3 |
Sudafrica | 2 |
Operativa
Director/Board Member | 4 |
Private Equity Investor | 2 |
Corporate Officer/Principal | 1 |
Sectorial
Consumer Services | 4 |
Health Services | 3 |
Commercial Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
UCB | Health Technology |
Empresas privadas | 6 |
---|---|
Lumos Pharma Sub, Inc.
![]() Lumos Pharma Sub, Inc. Medical/Nursing ServicesHealth Services Lumos Pharma Sub, Inc. develops and commercializes a novel treatment for the rare disease creatine transporter deficiency. It focuses on bringing novel therapies to patients afflicted with unmet medical needs in severe, rare, and genetic diseases. The firm's technology LUM-001 is a repurposed small molecule that is a kinetically similar analog of creatine and has shown promising therapeutic potential for the treatment of creatine transporter deficiency. Lumos Pharma was founded by Richard J. Hawkins in 2010 and is headquartered in Austin, TX. | Health Services |
Syndesi Therapeutics SA
![]() Syndesi Therapeutics SA Miscellaneous Commercial ServicesCommercial Services Syndesi Therapeutics SA develops novel therapeutics for cognitive impairment which includes Alzheimer’s disease, dementias, and cognitive impairment associated with schizophrenia. The company is headquartered in Louvain-la-Neuve, Belgium. | Commercial Services |
UCB Ventures (Private Equity)
![]() UCB Ventures (Private Equity) Investment ManagersFinance UCB Ventures is the venture capital arm of UCB SA and was founded in 2016. UCB Ventures is headquartered in Brussels, Belgium with additional offices in Boston, Massachusetts and London, United Kingdom. | Finance |
Walden Biosciences, Inc.
![]() Walden Biosciences, Inc. Medical/Nursing ServicesHealth Services Walden Biosciences, Inc. provides renal therapeutics services. The company is headquartered in Cambridge, MA. | Health Services |
EsoBiotec SA
![]() EsoBiotec SA Miscellaneous Commercial ServicesCommercial Services EsoBiotec SA is a Belgian company that provides research and development on natural sciences and engineering. The company is based in Charleroi, Belgium. The company was founded in 2020 by Jean-Pierre Latere. Jean-Pierre Latere has been the CEO since 2020. | Commercial Services |
Arix Bioscience /Venture Capital/
![]() Arix Bioscience /Venture Capital/ Investment ManagersFinance Arix Bioscience /Venture Capital/ (Arix Bioscience) is a venture capital subsidiary of Arix Bioscience Plc founded in 2015 by Christopher Thomas Evans, Jonathan M. Peacock and Joseph Anderson. The firm is headquartered in London, United Kingdom with an additional offices in New York. | Finance |
- Bolsa de valores
- Insiders
- Emmanuel Lacroix
- Experiencia